---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-26-000019"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2026-02-09T23:59:59+00:00"
generated_at: "2026-05-16T04:00:47.826249+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Labcorp appoints John H. Sampson, M.D., Ph.D., to board of directors

## Summary
- Appointed John H. Sampson, M.D., Ph.D., to Board of Directors, effective February 9, 2026.
- Dr. Sampson is vice chancellor for health affairs and dean at CU Anschutz School of Medicine.
- He brings expertise in oncology, neuroscience, women's health, and personalized medicine.
- Previously senior vice president at Duke Health Integrated Practice.
- Will serve on the Quality and Compliance Committee of the Board.

## SEC filing metadata
- accession: 0000920148-26-000019
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2026-02-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014826000019/0000920148-26-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014826000019/lh-20260206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-26-000019
- JSON: https://secwatch.observer/filing/0000920148-26-000019.json
- Plain text: https://secwatch.observer/filing/0000920148-26-000019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.